Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study

Virginia Solitano, Paola Facheris, Magnus Petersen, Ferdinando D'Amico, Michela Ortoncelli, Daniel Aletaha, Pablo A. Olivera, Thomas Bieber, Sofia Ramiro, Subrata Ghosh, Maria Antonietta D'Agostino, Britta Siegmund, Isabelle Chary-Valckenaere, Ailsa Hart, Lorenzo Dagna, Fernando Magro, Renaud Felten, Paulo Gustavo Kotze, Vipul Jairath, Antonio Costanzo, Lars Erik Kristensen, Laurent Peyrin Biroulet, Silvio Danese

Open source

DOI: 10.1016/j.autrev.2023.103504
Published: 2024-03
Container: Autoimmunity Reviews
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.autrev.2023.103504,
  title = {Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study},
  author = {Virginia Solitano and Paola Facheris and Magnus Petersen and Ferdinando D'Amico and Michela Ortoncelli and Daniel Aletaha and Pablo A. Olivera and Thomas Bieber and Sofia Ramiro and Subrata Ghosh and Maria Antonietta D'Agostino and Britta Siegmund and Isabelle Chary-Valckenaere and Ailsa Hart and Lorenzo Dagna and Fernando Magro and Renaud Felten and Paulo Gustavo Kotze and Vipul Jairath and Antonio Costanzo and Lars Erik Kristensen and Laurent Peyrin Biroulet and Silvio Danese},
  year = {2024},
  journal = {Autoimmunity Reviews},
  doi = {10.1016/j.autrev.2023.103504},
  url = {https://doi.org/10.1016/j.autrev.2023.103504}
}

RIS

TY  - JOUR
TI  - Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study
AU  - Virginia Solitano
AU  - Paola Facheris
AU  - Magnus Petersen
AU  - Ferdinando D'Amico
AU  - Michela Ortoncelli
AU  - Daniel Aletaha
AU  - Pablo A. Olivera
AU  - Thomas Bieber
AU  - Sofia Ramiro
AU  - Subrata Ghosh
AU  - Maria Antonietta D'Agostino
AU  - Britta Siegmund
AU  - Isabelle Chary-Valckenaere
AU  - Ailsa Hart
AU  - Lorenzo Dagna
AU  - Fernando Magro
AU  - Renaud Felten
AU  - Paulo Gustavo Kotze
AU  - Vipul Jairath
AU  - Antonio Costanzo
AU  - Lars Erik Kristensen
AU  - Laurent Peyrin Biroulet
AU  - Silvio Danese
PY  - 2024
JO  - Autoimmunity Reviews
DO  - 10.1016/j.autrev.2023.103504
UR  - https://doi.org/10.1016/j.autrev.2023.103504
ER  -

APA

Solitano, V., Facheris, P., Petersen, M., D'Amico, F., Ortoncelli, M., Aletaha, D., Olivera, P. A., Bieber, T., Ramiro, S., Ghosh, S., D'Agostino, M. A., Siegmund, B., Chary-Valckenaere, I., Hart, A., Dagna, L., Magro, F., Felten, R., Kotze, P. G., Jairath, V., Costanzo, A., Kristensen, L. E., Biroulet, L. P., & Danese, S. (2024). Implementation of regulatory guidance for JAK inhibitors use in patients with immune-mediated inflammatory diseases: An international appropriateness study. Autoimmunity Reviews. https://doi.org/10.1016/j.autrev.2023.103504

Source records

crossref · retrieved 2026-09-26T05:24:40.489Z